vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.

Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $108.2M, roughly 1.3× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs -2.3%, a 48.1% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 9.1%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $-7.8M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 8.3%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”

ANAB vs PRPL — Head-to-Head

Bigger by revenue
PRPL
PRPL
1.3× larger
PRPL
$140.7M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+142.0% gap
ANAB
151.1%
9.1%
PRPL
Higher net margin
ANAB
ANAB
48.1% more per $
ANAB
45.8%
-2.3%
PRPL
More free cash flow
ANAB
ANAB
$105.8M more FCF
ANAB
$98.0M
$-7.8M
PRPL
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
8.3%
PRPL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANAB
ANAB
PRPL
PRPL
Revenue
$108.2M
$140.7M
Net Profit
$49.6M
$-3.2M
Gross Margin
41.9%
Operating Margin
61.8%
-1.6%
Net Margin
45.8%
-2.3%
Revenue YoY
151.1%
9.1%
Net Profit YoY
327.8%
62.1%
EPS (diluted)
$1.64
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
PRPL
PRPL
Q4 25
$108.2M
$140.7M
Q3 25
$76.3M
$118.8M
Q2 25
$22.3M
$105.1M
Q1 25
$27.8M
$104.2M
Q4 24
$43.1M
$129.0M
Q3 24
$30.0M
$118.6M
Q2 24
$11.0M
$120.3M
Q1 24
$7.2M
$120.0M
Net Profit
ANAB
ANAB
PRPL
PRPL
Q4 25
$49.6M
$-3.2M
Q3 25
$15.1M
$-11.7M
Q2 25
$-38.6M
$-17.3M
Q1 25
$-39.3M
$-19.1M
Q4 24
$-21.8M
$-8.5M
Q3 24
$-32.9M
$-39.2M
Q2 24
$-46.7M
$27.0K
Q1 24
$-43.9M
$-50.2M
Gross Margin
ANAB
ANAB
PRPL
PRPL
Q4 25
41.9%
Q3 25
42.8%
Q2 25
35.9%
Q1 25
39.4%
Q4 24
42.9%
Q3 24
29.7%
Q2 24
40.7%
Q1 24
34.8%
Operating Margin
ANAB
ANAB
PRPL
PRPL
Q4 25
61.8%
-1.6%
Q3 25
45.5%
-10.2%
Q2 25
-117.5%
-13.5%
Q1 25
-99.2%
-13.9%
Q4 24
-22.4%
-6.0%
Q3 24
-75.8%
-39.5%
Q2 24
-367.5%
-12.1%
Q1 24
-587.8%
-19.3%
Net Margin
ANAB
ANAB
PRPL
PRPL
Q4 25
45.8%
-2.3%
Q3 25
19.8%
-9.9%
Q2 25
-173.5%
-16.5%
Q1 25
-141.6%
-18.4%
Q4 24
-50.5%
-6.6%
Q3 24
-109.4%
-33.1%
Q2 24
-425.3%
0.0%
Q1 24
-612.0%
-41.8%
EPS (diluted)
ANAB
ANAB
PRPL
PRPL
Q4 25
$1.64
$0.03
Q3 25
$0.52
$0.11
Q2 25
$-1.34
$0.16
Q1 25
$-1.28
$0.18
Q4 24
$-0.63
$0.08
Q3 24
$-1.14
$0.36
Q2 24
$-1.71
$0.00
Q1 24
$-1.64
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
PRPL
PRPL
Cash + ST InvestmentsLiquidity on hand
$238.2M
$24.3M
Total DebtLower is stronger
$126.7M
Stockholders' EquityBook value
$37.2M
$-29.7M
Total Assets
$364.4M
$296.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
PRPL
PRPL
Q4 25
$238.2M
$24.3M
Q3 25
$109.8M
$32.4M
Q2 25
$44.3M
$34.2M
Q1 25
$98.6M
$21.6M
Q4 24
$123.1M
$29.0M
Q3 24
$191.6M
$23.4M
Q2 24
$71.8M
$23.4M
Q1 24
$53.7M
$34.5M
Total Debt
ANAB
ANAB
PRPL
PRPL
Q4 25
$126.7M
Q3 25
Q2 25
Q1 25
Q4 24
$70.7M
Q3 24
$50.8M
Q2 24
Q1 24
Stockholders' Equity
ANAB
ANAB
PRPL
PRPL
Q4 25
$37.2M
$-29.7M
Q3 25
$-29.4M
$-26.9M
Q2 25
$-44.7M
$-15.6M
Q1 25
$34.0M
$1.3M
Q4 24
$70.9M
$20.2M
Q3 24
$84.4M
$28.0M
Q2 24
$9.9M
$66.4M
Q1 24
$47.8M
$65.5M
Total Assets
ANAB
ANAB
PRPL
PRPL
Q4 25
$364.4M
$296.3M
Q3 25
$353.1M
$302.1M
Q2 25
$335.3M
$303.8M
Q1 25
$422.1M
$293.8M
Q4 24
$483.8M
$307.8M
Q3 24
$493.4M
$309.3M
Q2 24
$427.4M
$362.1M
Q1 24
$405.8M
$382.1M
Debt / Equity
ANAB
ANAB
PRPL
PRPL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.50×
Q3 24
1.82×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
PRPL
PRPL
Operating Cash FlowLast quarter
$98.0M
$-5.8M
Free Cash FlowOCF − Capex
$98.0M
$-7.8M
FCF MarginFCF / Revenue
90.5%
-5.5%
Capex IntensityCapex / Revenue
0.0%
1.4%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$19.6M
$-41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
PRPL
PRPL
Q4 25
$98.0M
$-5.8M
Q3 25
$-27.4M
$-968.0K
Q2 25
$-40.2M
$-4.0M
Q1 25
$-10.7M
$-23.1M
Q4 24
$-66.7M
$6.8M
Q3 24
$-10.1M
$1.1M
Q2 24
$-21.3M
$-8.9M
Q1 24
$-37.3M
$-16.8M
Free Cash Flow
ANAB
ANAB
PRPL
PRPL
Q4 25
$98.0M
$-7.8M
Q3 25
$-27.4M
$-1.8M
Q2 25
$-40.3M
$-7.0M
Q1 25
$-10.7M
$-25.3M
Q4 24
$-66.9M
$5.7M
Q3 24
$-10.1M
$101.0K
Q2 24
$-21.4M
$-11.0M
Q1 24
$-37.3M
$-19.9M
FCF Margin
ANAB
ANAB
PRPL
PRPL
Q4 25
90.5%
-5.5%
Q3 25
-35.9%
-1.5%
Q2 25
-180.9%
-6.6%
Q1 25
-38.7%
-24.3%
Q4 24
-155.3%
4.4%
Q3 24
-33.7%
0.1%
Q2 24
-194.6%
-9.2%
Q1 24
-519.3%
-16.5%
Capex Intensity
ANAB
ANAB
PRPL
PRPL
Q4 25
0.0%
1.4%
Q3 25
0.0%
0.7%
Q2 25
0.2%
2.8%
Q1 25
0.1%
2.2%
Q4 24
0.6%
0.8%
Q3 24
0.1%
0.9%
Q2 24
0.3%
1.7%
Q1 24
0.4%
2.5%
Cash Conversion
ANAB
ANAB
PRPL
PRPL
Q4 25
1.98×
Q3 25
-1.81×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-330.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANAB
ANAB

Segment breakdown not available.

PRPL
PRPL

Cost Of Revenues$81.7M58%
Other$59.0M42%

Related Comparisons